Refractory Malignant Solid Neoplasm

DrugDrug NameDrug Description
DrugDrug NameTargetType
DrugDrug NamePhaseStatusCount
DB08885Aflibercept1Recruiting1
DB08875Cabozantinib1Active Not Recruiting1
DB04849Cediranib1Active Not Recruiting1
DB11841Entinostat1Recruiting1
DB00762Irinotecan1Recruiting2
DB01229Paclitaxel1Recruiting1
DB09037Pembrolizumab1Recruiting1
DB11759Pevonedistat1Recruiting1
DB12008Prexasertib1Recruiting1
DB00740Riluzole1Active Not Recruiting1
DB11836Sapanisertib1Recruiting1
DB11942Selinexor1Recruiting1
DB11689Selumetinib1Active Not Recruiting1
DB00398Sorafenib1Active Not Recruiting1
DB00853Temozolomide1Recruiting2
DB00515Cisplatin1 / 2Recruiting1
DB08865Crizotinib1 / 2Completed1
DB06186Ipilimumab1 / 2Recruiting1
DB00762Irinotecan1 / 2Recruiting1
DB11740MK-17751 / 2Recruiting1
DB06328Methoxyamine1 / 2Recruiting1
DB12117Mitometh1 / 2Recruiting1
DB09035Nivolumab1 / 2Recruiting1
DB00642Pemetrexed1 / 2Recruiting1
DB12257Platinum1 / 2Recruiting1
DB12218AZD-53632Recruiting1
DB08916Afatinib2Recruiting1
DB11967Binimetinib2Recruiting1
DB08875Cabozantinib2Recruiting1
DB12483Copanlisib2Recruiting1
DB08865Crizotinib2Recruiting1
DB08912Dabrafenib2Recruiting1
DB01254Dasatinib2Recruiting1
DB12282Defactinib2Recruiting1
DB12147Erdafitinib2Recruiting3
DB11795GSK-26367712Recruiting1
DB12167LY-30234142Recruiting2
DB14723Larotrectinib2Recruiting3
DB11740MK-17752Recruiting2
DB09035Nivolumab2Recruiting1
DB09074Olaparib2Recruiting2
DB09330Osimertinib2Recruiting1
DB09073Palbociclib2Recruiting2
DB06366Pertuzumab2Recruiting1
DB11836Sapanisertib2Recruiting1
DB11689Selumetinib2Recruiting2
DB01268Sunitinib2Recruiting1
DB12108Taselisib2Recruiting1
DB12887Tazemetostat2Recruiting1
DB08911Trametinib2Recruiting1
DB05773Trastuzumab emtansine2Recruiting1
DB13930Ulixertinib2Recruiting2
DB08881Vemurafenib2Recruiting2
DB08828Vismodegib2Recruiting1
DB13104X-3962Recruiting2